Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-05 Sale |
2025-03-06 7:20 pm |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Chief Financial Officer |
10,320 | $6.9837 | $72,072 | 269,010 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 6:45 pm |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Chief Financial Officer |
248 | $4.98 | $1,235 | 154,330 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-06 7:43 pm |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
7,727 | $3.43 | $26,504 | 123,318 (Direct) |
View |
| 2023-11-16 Sale |
2023-11-20 5:30 pm |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
259 | $4.13 | $1,070 | 87,305 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 8:04 pm |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
3,529 | $8.5706 | $30,246 | 87,564 (Direct) |
View |
| 2022-11-16 Sale(A) |
2022-11-17 4:15 pm |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
307 | $8.87 | $2,723 | 47,358 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-17 06:00 am |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
959 | $8.87 | $8,506 | 46,706 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-08 9:00 pm |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
220 | $12.01 | $2,642 | 150,630 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Exercise |
2025-03-17 7:34 pm |
N/A 2026-11-08 |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Chief Financial Officer |
2,500 | $0 | 271,510 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-17 7:34 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Chief Financial Officer |
2,500 | $6.32 | 271,510 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 7:20 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Chief Financial Officer |
125,000 | $0 | 269,010 (Direct) |
View |
| 2024-05-15 Option Award |
2024-05-17 6:35 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Chief Financial Officer |
31,260 | $0 | 154,578 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 7:43 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
43,740 | $0 | 123,318 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 8:04 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
43,735 | $0 | 87,564 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 9:00 pm |
N/A 2032-03-04 |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
144,151 | $0 | 150,630 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 8:00 pm |
N/A 2031-11-15 |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
13,429 | $0 | 16,291 (Direct) |
View |
Ownership |
2021-11-03 9:00 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | PISKEL KYLE Principal Accounting Officer |
0 | $0 | 61,620 (Direct) |
View |